SSI Strategy Holdings LLC (“SSI Strategy” or the “Company”), a leading Life Sciences consultancy, announced on December 21, 2020 that it received a growth investment from Amulet Capital Partners, LP (“Amulet”), a middle-market private equity firm focused exclusively on the Healthcare sector. SSI Strategy is an industry-leading provider of strategic consulting services for scientific functions within Life Sciences companies. The SSI Strategy team supports critical initiatives for Life Sciences companies, ranging in size from emerging biotechs to global leaders. Amulet’s investment, the first institutional funding taken by the Company, will accelerate the growth of SSI Strategy’s team and the expansion of strategic services to support Medical, Clinical and other critical path functions at the C-level of Life Sciences companies.
The GEABP team of KC Chiang, Eric Tausner and Mark Denton served as counsel to SSI Strategy in this investment. Additional information can be found here.